99% Savings - Buy Just @1 Rs X
Gembio is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Bronchitis. Secondary and off-label uses of Gembio have also been mentioned below.
The right dosage of Gembio depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Gembio include Nausea or vomiting, Diarrhoea, Dizziness. Besides the aforementioned side effects, there are other adverse effects of Gembio as well, which are listed below. These side effects of Gembio are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Gembio's effect during pregnancy is Moderate and Severe while nursing. It is important to know if Gembio has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gembio related warnings section.
Individuals suffering from medical conditions like Myasthenia Gravis (MG), Heart Disease, Tendon Injury (Tendinopathy) must refrain from the use of Gembio since this can cause severe adverse effects. The section on Gembio contraindications lists all such conditions.
Drug interactions for Gembio have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Gembio is considered not safe while driving, and is not addictive.
Gembio is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gembio safe for pregnant women?
Gembio can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Gembio right away. Take your doctor's advice before taking it again.
Is the use of Gembio safe during breastfeeding?
Gembio may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Gembio on the Kidneys?
Very few cases of side effects of Gembio on kidney have been reported.
What is the effect of Gembio on the Liver?
Gembio is completely safe for the liver.
What is the effect of Gembio on the Heart?
Gembio has very mild side effects on the heart.
Gembio should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gembio unless your doctor advises you to do so -
Is this Gembio habit forming or addictive?
No, you will not get addicted to Gembio.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Gembio can make you feel drowsy.
Is it safe?
Yes, but consume Gembio only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Gembio for mental disorders.
Interaction between Food and Gembio
When consumed with certain foods, Gembio may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Gembio
It is difficult to say anything about the effect of Gembio and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Factive® (gemifloxacin mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584